CLINICAL ROLE -
Another Look at Failed Alzheimer Disease Drug Trial
The exact etiology of Alzheimer's is unknown, and therefore, no cure exists.
EXPEDITION 3 Study: Is It Really a Failure?
Solanezumab did not significantly affect cognitive decline compared with the placebo in subjects with mild Alzheimer's, but there are still takeaways.
Heparin-induced Thrombocytopenia: A Guide for Pharmacists
Pharmacists often encounter patients with Heparin-induced Thrombocytopenia (HIT) in health care settings. Here are some useful information in regards to HIT.
Should Tissue Plasminogen Activator (tPA) Administration be Considered for the 3 to 4.5 Hours Range?
Tissue Plasminogen Activator (tPA) is administered in patients with Acute Ischemic Stroke. Becuase tPA administration is time sensitive, caution is required.
Statin Therapy in Patients with Diabetes
HMG-CoA reductase inhibitors are a class of lipid-lowering medications. Here is a look at guidelines and studies for health care professionals.
2 Clarke Drive Cranbury, NJ 08512